https://alzheimereurope.newsweaver.com/Newsletter/ en-us 02 Jul 2026 04:30:03 CEST 02 Jul 2026 04:30:03 CEST https://alzheimereurope.newsweaver.com/Newsletter/rss.xml Newsweaver info@alzheimer-europe.org () support@newsweaver.ie (Newsweaver) 60 true https://alzheimereurope.newsweaver.com/Newsletter/1ctf071q17c?lang=en&rss=true Alzheimer Europe's June 2026 newsletter [ https://alzheimereurope.newsweaver.com/Newsletter/8i1lmmgg65u/external?lang=en ] brings you the latest news on developments in the dementia field, across Europe and beyond. Summaries of a few of our top stories appear below. Our monthly newsletter reaches almost 11,000 people, who have an interest in dementia, from across Europe and beyond. We are always happy to receive feedback, or suggestions regarding news items to share. [ https://alzheimereurope.newsweaver.com/Newsletter/8i1lmmgg65u/external?lang=en ] 02 Jul 2026 12:00:00 CEST cc58d229fab4781e0c2035b659478d43 Other Articles <p style="text-align: justify;"><span style="font-size: 12px;"><img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/19/ea8a85fca407401059a769.jpg" style="margin: 5px;" width="133" height="200" hspace="5" vspace="5" alt="Executive Director Jean Georges, June 2024">Alzheimer Europe's<span style="color: #000000;"><strong> </strong></span></span><span style="font-size: 12px;"><a href="https://alzheimereurope.newsweaver.com/Newsletter/8i1lmmgg65u/external?lang=en" target="_blank" rel="noreferrer noopener"><span style="color: #000000;"><strong><strong>June 2026 newsletter</strong> </strong></span></a>brings you the latest news on developments in the dementia field, across Europe and beyond.</span></p> <p style="text-align: justify;"><span style="font-size: 12px;">Summaries of a few of our top stories appear below.</span></p> <p style="text-align: justify;"><span style="font-size: 12px;">Our monthly newsletter reaches almost 11,000 people, who have an interest in dementia, from across Europe and beyond.</span></p> <p style="text-align: justify;"><span style="font-size: 12px;">We are always happy to receive feedback, or suggestions regarding news items to share.</span></p> <p style="text-align: justify;"> </p> <p class="centered-only" style="text-align: center;"><a href="https://alzheimereurope.newsweaver.com/Newsletter/8i1lmmgg65u/external?lang=en" target="_blank" rel="noreferrer noopener"><img align="middle" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/33/9a2b2c753c2ca4ee114ecc.jpg" style="margin: 0px;" width="200" height="48" hspace="0" vspace="0" alt=""></a></p> https://alzheimereurope.newsweaver.com/Newsletter/10h4hyh1gp7?lang=en&rss=true On 8 June, Alzheimer Europe published a position paper calling for equitable and timely access to lecanemab and donanemab, the first disease-modifying therapies for Alzheimer's disease authorised in the European Union. Developed following consultation with national member associations, the European Working Group of People with Dementia (EWGPWD) and the European Dementia Carers Working Group (EDCWG), the paper sets out five areas of concern and calls for concrete action from governments, health technology assessment (HTA) bodies, manufacturers and the research community. 02 Jul 2026 12:00:00 CEST 0a76fa003aa52ca13f4c18fe653aaf2d Other Articles <p style="text-align: justify;"><span style="font-size: 12px;"><img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/8a/cbfe7eeb725adf05fad6ea.jpg" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="AE logo square">On 8 June, Alzheimer Europe published a position paper calling for equitable and timely access to lecanemab and donanemab, the first disease-modifying therapies for Alzheimer's disease authorised in the European Union. Developed following consultation with national member associations, the European Working Group of People with Dementia (EWGPWD) and the European Dementia Carers Working Group (EDCWG), the paper sets out five areas of concern and calls for concrete action from governments, health technology assessment (HTA) bodies, manufacturers and the research community.</span></p> https://www.alzheimer-europe.org/news/alzheimer-europe-calls-equitable-access-new-alzheimers-disease-treatments-across-europe https://alzheimereurope.newsweaver.com/Newsletter/6hi5egnzl1b?lang=en&rss=true Alzheimer Europe is pleased to introduce issue 51 of the Dementia in Europe magazine! There has been much valuable work taking place across Europe in the domains of policy, research, culture and care, and we are delighted to showcase these in our magazine. 02 Jul 2026 12:00:00 CEST 00712183c46f1d4e6790b80be6c7e32b Other Articles <p style="text-align: justify;"><span style="font-size: 12px;"><img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/c8/cfe8409a87bba5a785aaf9.png" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="">Alzheimer Europe is pleased to introduce issue 51 of the Dementia in Europe magazine! There has been much valuable work taking place across Europe in the domains of policy, research, culture and care, and we are delighted to showcase these in our magazine.</span></p> https://www.alzheimer-europe.org/news/we-are-pleased-present-our-latest-dementia-europe-policy-magazine https://alzheimereurope.newsweaver.com/Newsletter/i0a0ysa5brv?lang=en&rss=true Alzheimer Europe is pleased to welcome three new member associations, a new Board of Directors for the 2026-2028 term, and to present its 2025 Annual and Financial Report. These are just three of the important outcomes from the organisation's Annual General Meeting (AGM), which took place on 30 June 2026, in Luxembourg. 02 Jul 2026 12:00:00 CEST a10f9214c376d7b4a561083ed65002eb Other Articles <p style="text-align: justify;"><span style="font-size: 12px;"><img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/f9/164fdf0de06638d1b015b4.jpg" style="margin:5px;" width="150" height="108" hspace="5" vspace="5" alt="">Alzheimer Europe is pleased to welcome three new member associations, a new Board of Directors for the 2026-2028 term, and to present its 2025 Annual and Financial Report. These are just three of the important outcomes from the organisation's Annual General Meeting (AGM), which took place on 30 June 2026, in Luxembourg. </span></p> https://www.alzheimer-europe.org/news/our-2026-agm-luxembourg-welcomes-three-new-member-associations-new-board-directors-alzheimer https://alzheimereurope.newsweaver.com/Newsletter/1n8gci7ltv9?lang=en&rss=true As preparations are underway for the next Alzheimer Europe conference in beautiful Dublin, the early bird registration for the event has closed on 30 June, with more than 1,000 delegates already registered, but don't worry, standard registrations will remain open until 26 October! 02 Jul 2026 12:00:00 CEST 9725446d0b0955e6da44a0f0dad2ec85 Other Articles <p style="text-align: justify;"><span style="color: #000000; font-family: Arial, Helvetica, sans-serif; font-size: 12px; text-align: justify; white-space: normal; background-color: #ffffff; float: none; display: inline;"><img align="left" src="https://alzheimereurope.newsweaver.com/v3files/shard1/56305/0a/c5b369bb90ceaaf49636ba.jpg" style="margin: 5px;" width="150" height="143" hspace="5" vspace="5" alt="">As preparations are underway for the next Alzheimer Europe conference in beautiful Dublin, the early bird registration for the event has closed on 30 June, with more than 1,000 delegates already registered, but don't worry, standard registrations will remain open until 26 October!</span></p> https://www.alzheimer-europe.org/news/early-bird-registration-now-closed-you-can-still-register-36aec